TRACON Pharmaceutical (TCON) Tops Q4 EPS by 23c

TRACON Pharmaceutical (NASDAQ: TCON) reported Q4 EPS of $, $0.23 better than the analyst estimate of ($0.23).

For earnings history and earnings-related data on TRACON Pharmaceutical (TCON) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Evolution Petroleum launches stock offering to fund Permian Basin deal
• Sypris Solutions (SYPR) Reports Q2 Loss of $0.14